Compare MITK & KMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MITK | KMDA |
|---|---|---|
| Founded | 1983 | 1990 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Computer peripheral equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 536.1M | 501.8M |
| IPO Year | 1995 | 2013 |
| Metric | MITK | KMDA |
|---|---|---|
| Price | $14.27 | $8.11 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $15.00 | $14.00 |
| AVG Volume (30 Days) | ★ 839.0K | 70.4K |
| Earning Date | 05-07-2026 | 03-11-2026 |
| Dividend Yield | N/A | ★ 2.94% |
| EPS Growth | ★ 171.43 | N/A |
| EPS | ★ 0.06 | N/A |
| Revenue | ★ $45,390,000.00 | N/A |
| Revenue This Year | $9.55 | $14.04 |
| Revenue Next Year | $8.07 | $7.99 |
| P/E Ratio | $234.83 | ★ $24.59 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.93 | $5.54 |
| 52 Week High | $15.61 | $9.35 |
| Indicator | MITK | KMDA |
|---|---|---|
| Relative Strength Index (RSI) | 54.85 | 38.54 |
| Support Level | $9.32 | $6.70 |
| Resistance Level | $15.61 | $8.30 |
| Average True Range (ATR) | 0.62 | 0.26 |
| MACD | -0.16 | -0.11 |
| Stochastic Oscillator | 27.46 | 4.55 |
Mitek Systems Inc is engaged in the development, sale, and service of proprietary software solutions related to mobile imaging. The firm is a software development company with expertise in artificial intelligence, and machine learning. It serves more than 7,900 financial services organizations, financial technology (fintech) brands, telecommunications companies, and marketplace brands across the globe. The company's Mobile Deposit solution is used by consumers for mobile check deposits. The company's Mobile Verify verifies a user's identity online, enabling organizations to build safer digital communities, whereas CheckReader enables financial institutions to automatically extract data from a check image received across any deposit channel - branch, ATM, RDC, and mobile.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.